Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis

Published:2023-01 Issue:1 Volume:29 Page:13-21
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Albuquerque Arthur M.,Eckert Igor,Tramujas Lucas,Butler-Laporte Guillaume,McDonald Emily G.,Brophy James M.,Lee Todd C.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference63 articles.

1. Remdesivir for the treatment of COVID-19: an updated systematic review and meta-analysis [e-pub ahead of print];Lee;Clin Microbiol Infect,2022

2. Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19;N Engl J Med,2021

3. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial;Abani;Lancet,2022

4. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis;Sterne;JAMA,2020

5. Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis;JAMA,2021

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19;Journal of Infection;2024-10

2. N-acetyl-cysteine in Intensive Care Unit Patients with Acute Respiratory Distress Syndrome due to COVID-19: A Retrospective Cohort Study;Journal of Intensive Care Medicine;2024-09-11

3. Harnessing immunity: Immunomodulatory therapies in COVID-19;World Journal of Virology;2024-06-25

4. Clinical Outcomes among Hospitalized COVID-19 Patients Who Received Baricitinib or Tocilizumab in Addition to Standard of Care;Diseases;2024-05-20

5. Targeting IL-6 trans-signalling by sgp130Fc attenuates severity in SARS-CoV-2 -infected mice and reduces endotheliopathy;eBioMedicine;2024-05